The Changing Oncology Landscape

Dr. Franklin Smith, Medpace’s vice president of medical affairs and specialist in hematology oncology, reflects on advances in oncology drug development. Read his insights on how the landscape for oncology treatment changed, given the breakthroughs in cancer immunotherapy and precision medicine as well as key challenges in designing protocols for oncology studies and how those protocols will impact advances in oncology drug development.